Metraipolis › archive › dc_54fee319fe7e

Efficacy and Safety of Lebrikizumab in Adults with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis — Europe PMC PMID:41827153

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41827153
DOI
10.3390/jcm15051737
License (as archived)
solo-consultazione
Archived
2026-11-05T12:16:18.261Z
SHA-256 of the archived text
db019758f05c732760aec23b6bff86cf825b333ae213e6ce77b7d61342c8ffca
Stable URL of this page
https://metraipolis.com/documento/dc_54fee319fe7e

How to cite

Efficacy and Safety of Lebrikizumab in Adults with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis — Europe PMC PMID:41827153 — Europe PMC (en), https://europepmc.org/article/MED/41827153 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_54fee319fe7e (Metraipolis archive dc_54fee319fe7e, sha256 db019758f05c732760aec23b6bff86cf825b333ae213e6ce77b7d61342c8ffca)
BibTeX
@misc{dc54fee319fe7e,
  title = {Efficacy and Safety of Lebrikizumab in Adults with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis — Europe PMC PMID:41827153},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41827153},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_54fee319fe7e; sha256 db019758f05c732760aec23b6bff86cf825b333ae213e6ce77b7d61342c8ffca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41827153. Agents can read the archived copy with the MCP tool read_document.